<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is the third most common form of human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Diverse therapies such as surgery and chemotherapy have shown excellent results in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>However, they still have limitations </plain></SENT>
<SENT sid="3" pm="."><plain>There is a need to develop new <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> treatment strategies </plain></SENT>
<SENT sid="4" pm="."><plain>Probiotic formulations have shown excellent promises in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> as modest, preventive and early stage therapeutics </plain></SENT>
<SENT sid="5" pm="."><plain>This review summarizes the recent development of probiotics in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and highlights the importance of the intestinal microbiota balance in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, cover current research on probiotics for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> prevention and treatment with emphasis on the mechanisms involved </plain></SENT>
<SENT sid="6" pm="."><plain>Specifically, this report describes evidences on the role of probiotics in inhibiting <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e>, in reducing <z:mp ids='MP_0003674'>oxidative stress</z:mp>, in reducing colon cell DNA damage, in producing anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> compounds, in improving the microflora balance, in stimulating the host immune response and in other physiochemical conditions of the gut </plain></SENT>
<SENT sid="7" pm="."><plain>Even though, some of these effects were observed in several human trials when probiotics formulations were used as a supplement with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> therapies, the application of probiotics as a biotherapeutic against <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> still needs further investigations </plain></SENT>
</text></document>